JF

Jason Foster

Investment Committee at Altius bioventures

London, England

Overview 

Jason Foster is the Chief Executive Officer and Executive Director at Ori Biotech in London, England. With a background in market research and pharmaceutical industry, he has excelled in roles such as Managing Director at Health Equity Consulting Ltd and serving on the Investment Committee at Altius bioventures. Foster's career highlights include leading Ori Biotech, a company focused on innovative solutions in the pharmaceutical industry, and serving as a Strategic Advisor at Ataraxia Partners, showcasing his expertise in market analysis and product development within the healthcare sector.

Work Experience 

  • Chief Executive Officer and Executive Director

    2019 - Current

    Ori Biotech is on a mission to enable widespread patient access to life saving cell and gene therapies (CGTs). Ori has developed a proprietary, flexible manufacturing platform that closes, automates and standardises CGT manufacturing allowing therapeutics developers to seamlessly bring their products from pre-clinical process development to commercial scale manufacturing.

  • Investment Committee

    2023

    A venture studio with an early-stage fund and a global ecosystem of support for efficiently launching cutting-edge companies developing tools and technologies in the Cell and Gene Therapy space.

  • Managing Director

    2016

    Health Equity Consulting (HEC) is a global growth consultancy focused on increasing the value of companies, products and brands in the healthcare, pharmaceuticals, biotech, medical device, medtech and health & wellness arenas At HEC we mainly work with three types of clients: 1. Private Equity/Venture Capital firms looking for investments or desiring commercial expertise to help their portfolio companies grow 2. Growth stage companies which require strategic/operational/commercial support and/or connections to investment capital 3. Strategic corporate clients interested in driving growth organically or through licensing, investment or acquisition Diverse client base ranges from leading global venture capital and private equity firms to innovative growth stage companies working in pharmaceuticals, medical devices, drug discovery, healthTech, manufacturing technology, hospital services, OTC health, sports fitness and healthcare supply services.

  • Non Executive Director

    2018

    Enabling at-home and in-clinic rehabilitation for people who have had a stroke, TBI or another neurological condition

  • Chairman of the Board

    2020 - 2023

    Chaired the Board of Directors

  • Non Executive Director

    2019

    Credentially (formerly Dr Focused) has a SaaS solution that makes on-boarding and compliance for healthcare staff easy

  • Non Executive Director

    2018

    Increasing productivity for doctors, improving health outcomes for patients and streamlining activities for pharma using EHR data

  • Strategic Advisor

    2019

    By investing in the emerging science of happiness, Joyance Partners is the first venture fund focused on individual health experience, not process.

Ataraxia, an early stage fund manager focused on helping people live longer and live better.

  • Venture Partner

    2022

  • Venture Partner

    2017

    Senior healthcare adviser with a focus on sales, marketing and operations. Advise and mentor founders in a high-tech venture incubator and investment fund (spun out of Imperial Innovations) that brings together the UK’s best scientific talent to address large market opportunities at speed.

  • Mentor

    2017 - 2022

    Mentoring innovative companies in the healthtech, nutrition and wellness areas.

Techstars is an accelerator that provides pre-seed investment and mentoring for various early stage startups.

Raised $108,919,999.00 from SVB Financial Group and Foundry Group.

Articles About Jason

Relevant Websites